tbuckley/cabot-search huggingface dataset:
ENFORCED VACCINATION.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Manuscripts Approved for JNCI, September 15 to October 15, 1960
Journal: JNCI Journal of the National Cancer Institute (1960)

Journal Article Manuscripts Approved for JNCI, September 15 to October 15, 1960 Get access JNCI: Journal of the National Cancer Institute, Volume 25, Issue 5, November 1960, Pages 1195–1196, https://doi.org/10.1093/jnci/25.5.1195-a Published: 01 November 1960
National Standards for Diabetes Self-Management Education
Authors: Carolée Mensing, Jackie Boucher, Marjorie Cypress, Katie Weinger, Kathryn Mulcahy, Patricia Barta, Gwen Hosey, Wendy Kopher, Andrea Lasichak, Betty Lamb, Mavourneen Mangan, Jan Norman, Jon Tanja, Linda Yauk, Kimberlydawn Wisdom, Cynthia Adams
Journal: Diabetes Care (2003)
Ergebnisse der gesamten Tuberkuloseforschung
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Information Wanted.
Authors: R. Y. Ferguson
Journal: JAMA (1896)

Detroit, Feb. 25, 1896. <h3>To the Editor:</h3> —Will you kindly inform me through theJournalwhat the requirements are for the practice of medicine in Minnesota? If there is a State Board, and the address of the Secretary? How often and where the examinations are held? You will greatly oblige your reader, 297 Brush Street.
化脓性汗腺炎：患病率及相关因素
Journal: British Journal of Dermatology (2020)

我发现在美国和欧洲，HS 在 30 多岁和 40 多岁的女性中更常见，而在韩国，男性患 HS 的最多。吸烟和超重与 HS 有很大的关联。HS 患者比非 HS 患者出现心脏病和脑卒中的风险更高，也更容易死于心脏病和脑卒中。HS 患者更容易患抑郁症，且自杀率更高。我确认 HS 与其他慢性炎症性疾病有关。
The 'USHealth Act'. Comprehensive reform for a caring America
Authors: E R Roybal
Journal: JAMA (1991)

USHealth is a program proposed by Congressman Roybal to provide catastrophic and basic health coverage for all Americans, regardless of age, income, or illness. It would be managed by the USHealth Administration, an independent off-budget government agency, and would consolidate Medicare, Medicaid, and private insurance into a single insurance program. Roybal argues the case for his proposal, focusing on cost-containment; the expansion of coverage to include nursing and long-term care; the prioritization of quality assurance; financing along the lines of the current Medicare model; and commitment to "true" criteria: protection of the uninsured, protection of underinsured working families, short-term catastrophic protection for underinsured persons, containment of health care costs, assurance of quality care, and full financing now and in the foreseeable future.
Contrasting Testosterone Concentrations in Type 1 and Type 2 Diabetes
Authors: Rashmi Tomar, Sandeep Dhindsa, Ajay Chaudhuri, Priya Mohanty, Rajesh Garg, Paresh Dandona
Journal: Diabetes Care (2006)

e have recently reported (1) that male patients with type 2 diabetes have frequent hypogonadotrophic hypogonadism.We have now asked whether a similar defect may be observed in type 1 diabetic males to determine whether diabetes per se is the cause of hypogonadotrophic hypogonadism.
PARLIAMENTARY REPRESENTATION
Authors: N. B. Harman
Journal: BMJ (1918)

CTI 1 , t i a good deal of recenit Amilerican worlk lhas been added.Tlio existence of the opposite condition, "alkalosis," unless it occurs in parathyroid tetauy, has not justified its claim to definite recognition.The clear, and at the same time condensed, manner in wlich the ratlher difficult subject matter is treated is a(lmirable, and the present edition fully maintains the high standard and reputation of its predecessors. NOTES ON BOOKS.DR. RiUTHERFORD DARLING, assistant surgeon to the Soutflh Sydniey Hospital, setting out to write a handbook on preventive nursing in accordance with the syllabus laid (lown for the final examination of the Australian Trained NLurses' Association, has produced a book, Elementary Hygienc for Nitrscs, whiclh not only fulfils this purpose, but is also likely to be of use to students and junior memibers of the miiedical profession who are not seeliing a d1iplomna in public health.He deals in succession with ventilation, food, the sanitation of btuildings, water, sewage, the prevention of infectious diseases, parasites, an(d per- s-onal hygielle.There are a number of illustrations, many o them familiar, but well selected, and a good index.
GB Virus C Infection in Patients with Type II Cryoglobulinemia
Authors: Rocco Misiani
Journal: Annals of Internal Medicine (1998)

Letters1 May 1998GB Virus C Infection in Patients with Type II CryoglobulinemiaRocco Misiani, MD, Piermario Bellavita, MD, and Giovanni Mantero, PhDRocco Misiani, MDOspedale Riuniti di Bergamo; Bergamo 24128, ItalyConsorzio per le Biotecnologie; Brescia 25123, ItalySearch for more papers by this author, Piermario Bellavita, MDOspedale Riuniti di Bergamo; Bergamo 24128, ItalyConsorzio per le Biotecnologie; Brescia 25123, ItalySearch for more papers by this author, and Giovanni Mantero, PhDOspedale Riuniti di Bergamo; Bergamo 24128, ItalyConsorzio per le Biotecnologie; Brescia 25123, ItalySearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-9-199805010-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Zehender and colleagues report on a series of patients in whom the prevalence of HGV infection is much lower than that found in our study. We share their opinion that this discrepancy may be ascribed primarily to the different methods used to detect GB virus C and HGV RNA. Indeed, the high sensitivity of our assay is suggested by the elevated prevalence of GB virus C RNA not only in cryoglobulinemic patients with or without HCV infection but also in anti-HCV-positive blood donors. Furthermore, in another study using the same method, the GB virus C genome was detected ...References1. Fiordalisi G, Zanella I, Mantero G, Bettinardi A, Stellini R, Paraninfo G, et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis. 1996; 174:181-3. Google Scholar2. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med. 1996; 124(1 pt 1):31-4. Google Scholar Author, Article, and Disclosure InformationAffiliations: Ospedale Riuniti di Bergamo; Bergamo 24128, ItalyConsorzio per le Biotecnologie; Brescia 25123, Italy PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1998Volume 128, Issue 9Page: 779-780KeywordsAlanine aminotransferaseBlood donorsChronic hepatitisClinical epidemiologyGenomicsGeographic areasHepatitis APathogensRNAResearch design Issue Published: 1 May 1998 CopyrightCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
A phase I/II study of pexa-vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer: Safety report.
Authors: Maria Pia Morelli, Changqing Xie, Gagan Brar, Charalampos S. Floudas, Suzanne Fioravanti, Melissa Walker, Donna Mabry-Hrones, Tim F. Greten
Journal: Journal of Clinical Oncology (2019)

646 Background: The efficacy of immune checkpoint inhibitor has been limited to small portion of colorectal cancer (CRC) patients whose tumors with mismatch repair (MMR) gene abnormalities. There is an urgent need for patients with MMR proficient (pMMR) tumors. Oncolytic immunotherapy represents a novel therapeutic platform for the treatment of cancer with unique activity compared to conventional chemotherapy. The trial is to evaluate if the combination of Pexa-Vec oncolytic virus (PV) with immune checkpoint inhibition enhance antitumor immunity. Methods: Patients with microsatellite-stable and MSI-H mCRC refractory to PD-1 monotherapy were enrolled. Patients received either Arm A treated with PV + Durvalumab or Arm B with PV + Durvalumab and Tremelimumab. Each arm had two dose levels (DL) of PV, 3 x 10 8 pfu in DL1 and at 10 9 pfu in DL2, every 2 weeks for total 4 doses. The first dose of PV was administered on Day -12, followed by three more dose administration on Days 2, 16 and 30 in combination with the immune checkpoint inhibition. The primary endpoint is response rate, safety, tolerability and feasibility of these combination therapy in refractory metastatic CRC. Results: Here we report the safety data of Arm A.A total of 9 patients was enrolled so far. The longest follow-up time is 8 months. Four patients received DL1 PV and subsequent five patients received DL2 PV. No DLT was observed at the time of this abstract. No grade 4-5 adverse event (AE) were observed. All patients experienced lymphopenia. All patients with DL2 developed fever, hypotension and papulopastular rashes and were successfully managed with antipyretics, fluid support and skin protection, respectively. The most frequent treatment-related AEs were lymphopenia (8 [100%], fever (7 [87.5%]), chills (6 [75.0%]), hypotension (5 [62.5%]), papulopastular rashes (5 [62.5%], flu-like symptoms (2 [12.5%]), Nausea/vomiting (2 [12.5%]). Conclusions: Pexa-Vec in combination with Durvalumab showed a favorable safety profile. Clinical trial information: NCT03206073.
J Amer Vet Med Assoc, Chicago
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Biofeedback for fecal incontinence. Meningococcal vaccine found effective. Very young children may be immunized
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pädiatrische Praxis, Vienna
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatitis C and B-Cell Lymphoma
Authors: Eli Zuckerman
Journal: Annals of Internal Medicine (1998)

Letters15 April 1998Hepatitis C and B-Cell LymphomaEli Zuckerman, MD, Tsila Zuckerman, MD, and Alexandra M. Levine, MDEli Zuckerman, MDB'nai Zion Medical Center; Haifi, IsraelUniversity of Southern California; Los Angeles, CA 90033Search for more papers by this author, Tsila Zuckerman, MDB'nai Zion Medical Center; Haifi, IsraelUniversity of Southern California; Los Angeles, CA 90033Search for more papers by this author, and Alexandra M. Levine, MDB'nai Zion Medical Center; Haifi, IsraelUniversity of Southern California; Los Angeles, CA 90033Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-8-199804150-00023 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We were very interested to see the data from the City of Hope National Medical Center on seroprevalence of HCV infection in patients with B-cell non-Hodgkin lymphoma. Investigators at City of Hope have confirmed our finding of the increased prevalence of HCV infection in U.S. patients with lymphoma. Although Kashyap and colleagues state that the somewhat lower prevalence in their institution may be secondary to the lower percentage of black and Hispanic patients, it is important to ascertain whether the HCV-positive patients at City of Hope were, in fact, members of a racial or ethnic minority.Furthermore, Kashyap ...References1. McQuillan G, Alter M, Moyer L, Lambert S, Margolis H. A population based serologic study of hepatitis C virus infection in the United States [Abstract]. Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome; 1996:8A. Google Scholar2. Rosenvald-Zuckerman T, Zuckerman E, Duer D, Fong TL, Dian GD, Levine A. Liver function in HCV infected patients with hematological malignancies treated with chemotherapy [Abstract]. Blood. 1996; 88(Suppl 1):222a. Google Scholar Author, Article, and Disclosure InformationAffiliations: B'nai Zion Medical Center; Haifi, IsraelUniversity of Southern California; Los Angeles, CA 90033 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 April 1998Volume 128, Issue 8Page: 695KeywordsAntibodiesB cellsHepatitis CHispanic peopleInfectious diseasesInfectious hepatitisLiver diseasesLymphomaPathogenesisRNA Issue Published: 15 April 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Centers Needed to Study Women's Environmental Health
Authors: Maureen C. Hatch
Journal: Environmental Health Perspectives (2000)

The view of women as primarily fecund beings goes back to prehistory, where it is expressed in the well-known series of Venuses--stone figures of women with enlarged breasts, who are often represented as pregnant. Although the Venus figures date from the late Paleolithic era, this view of women did not change much in the next 20,000 years. With the approaching millennium, however, the field of health research has begun to consider women apart from their children or prospective progeny. Reflecting this shift in viewpoint, funds for research on the environmental health of women have now become available. However, no coordinated program has been launched on the scale of the newly established Centers for Children's Environmental Health and Disease Prevention Research (1). Should women, like children, be the focus of a concerted research effort?
Light‐chain paraproteins with lupus anticoagulant activity
Authors: Zahida Yasin, Donald Quick, Perumal Thiagarajan, Denise Spoor, Juan Caraveo, Joseph Palascak
Journal: American Journal of Hematology (1999)

A patient with newly diagnosed multiple myeloma manifested by urine kappa light-chain excretion and a small monoclonal spike (0.4 g/dl), presented with lower extremity deep venous thrombosis. A preheparin plasma-activated partial thromboplastin time (aPTT) was prolonged at 68 sec (normal control 26-42 sec). Additional studies confirmed the presence of lupus anticoagulant activity in the serum: the modified Russell Viper Venom Time (MRVVT) was 73 sec (normal control 24–42 sec) and with a 50:50 mix of the patient's plasma and pooled normal plasma, the MRVVT remained prolonged. Kappa light chains (LC) were isolated from the patient's urine and their purity confirmed by electrophoresis and immunofixation using specific immunoglobulin antisera. The patient's LC mixed with pooled normal plasma demonstrated LA activity by in vitro clotting tests (plasma-activated partial thromboplastin time 62 sec, with normal control of 45 sec), MRVVT of 44 sec with normal control of 35 sec. Purified urinary kappa light chains from a control patient with multiple myeloma and normal clotting studies, failed to prolong either the plasma-activated partial thromboplastin time or the MRVVT. We hypothesize that kappa LC in our patient demonstrated LA activity, which was unique to these LCs. Paraproteins with LA activity, to date, have included only intact immunoglobulins (Ig). While intact Ig paraproteins have been reported to possess LA activity, this is the first report to our knowledge of light-chain paraproteins possessing similar activity and resulting in clinically evident thrombosis. Light chain paraproteins could serve as useful models for further study of the mechanisms of activity of acquired LA inhibitors. Am. J. Hematol. 62:99–102, 1999. © 1999 Wiley-Liss, Inc.
Rheumatology
Authors: G. E. Ehrlich
Journal: JAMA (1978)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Esophageal angina
Journal: JAMA (1983)

<h3>In Reply.—</h3> Radioallergosorbent titration was considered in my discussion of "Controversial Practices in Allergy" and included comparison of modified RAST and Phadebas RAST. The report of Santrach et al<sup>1</sup>was cited, which examined non-IgE-containing control specimens. They reported that radioactive binding produced by fetal calf serum and pooled human cord serum was sufficient to score as class 1 in one of 21 modified RAST assays, whereas human serum albumin scored as class 1 in serum of 21 assays. It would have been more appropriate for me to state that non-IgE-containing control preparations produced "equivocal" results in up to seven of 21 modified RAST assays than to have referred to 33% false-positive results. This same study reported negative nasal provocation test results in five of eight modified RAST class 1 patients and underscored the relative nonspecificity of the class 1 designation. In 1980, Hoffman<sup>2</sup>reported results on comparison of